Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
Authors:
- Ruth PettengellRuth Pettengell
- Bertrand CoiffierBCBertrand Coiffier
- Geetha NarayananGeetha Narayanan
- Fernando Hurtado de MendozaFMFernando Hurtado de Mendoza
- Raghunadharao DigumartiRDRaghunadharao Digumarti
- Henry GomezHenry Gomez
- Pier Luigi ZinzaniPier Luigi Zinzani
- Gary SchillerGSGary Schiller
- David RizzieriDRDavid Rizzieri
- Giles BolandGBGiles Boland
- Paul CernohousPCPaul Cernohous
- Lixia WangLWLixia Wang
- 1 July 2012
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 13 (7) , 696-706
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphomaAnnals of Oncology, 2011
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab EraJournal of Clinical Oncology, 2010
- Pixantrone for the treatment of aggressive non-Hodgkin lymphomaExpert Opinion on Pharmacotherapy, 2010
- Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- Immunochemotherapy: The new standard in aggressive non-Hodgkin's lymphoma in the elderlySeminars in Oncology, 2003
- A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's LymphomaLeukemia & Lymphoma, 2002
- Human Heart Cytosolic Reductases and Anthracycline CardiotoxicityIUBMB Life, 2001
- Treatment advances in non-Hodgkin’s lymphomaExpert Opinion on Pharmacotherapy, 2000